Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial.

Clarke, Ed; Bashorun, Adedapo O; Okoye, Michael; Umesi, Ama; Badjie Hydara, Mariama; Adigweme, Ikechukwu; Dhere, Rajeev; Sethna, Vistasp; Kampmann, Beate; Goldblatt, David; +5 more... Tate, Andi; Weiner, Debra H; Flores, Jorge; Alderson, Mark R; Lamola, Steve; (2020) Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial. Vaccine, 38 (2). pp. 399-410. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2019.08.072

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2019.08.072

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID 31843266
Elements ID 142281

Share

Download

Filename: 1-s2.0-S0264410X1931148X-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar